This isn't a staffing problem. It's an infrastructure problem.
140 million Americans visit an emergency department every year.1 400,000 die from preventable medical errors4 - that's the equivalent of two fully loaded 747s crashing every single day. 80% of those errors trace back to miscommunication.3
Hospitals use systems built to document, not to coordinate. The actual front door - where patients wait, where nurses type, where everything slows down - nobody's rebuilt that. We are.
Systems Built to Document, Not Coordinate
EHR platforms store records. They don't move information in real time to the people who need it most.
The Front Door Is Broken
Where patients wait, where nurses type, where everything slows down - nobody has rebuilt this.
Patients are paying the price for a system that hasn't been redesigned in decades.
Why We Built This
Born from a real ER experience.
Our founder walked into an emergency room with a torn shoulder and waited five hours - not because there were no doctors, but because a nurse was buried in paperwork, manually entering information into a system nobody else in the room could even see. That moment is why MediBridge™ exists.
JC
Jungly Chen
Founder & CEO
Building MediBridge™ after experiencing firsthand how broken emergency department workflows are. Focused on turning that frustration into infrastructure that saves lives.
What We Do
Purpose-built for emergency medicine.
A clinical intelligence platform designed from the ground up for the unique demands of the emergency department.
Streamlined Intake
A faster, smarter way to capture patient information at the front door of the ED.
Intelligent Prioritization
Helping clinicians identify the most urgent cases faster with decision support tools.
Team Visibility
Giving the entire care team a shared, real-time picture of what's happening in the department.
HIPAA-Ready Architecture
Encryption, access controls, and compliance infrastructure designed for healthcare from day one. BAA execution on pilot.
System Compatibility
Designed to work within existing hospital infrastructure and clinical workflows.
Measurable Impact
Designed to improve patient outcomes, staff satisfaction, and operational efficiency.
The Experience
Clinical intelligence, not just software.
MediBridge™ uses proprietary technology to transform how emergency departments handle patient flow - from the moment a patient arrives to the moment they're seen.
Less friction. Fewer gaps. Better outcomes.
MediBridge™ AI
Hi, I'm your virtual intake assistant. What brings you in today?
Interactive Demo - Try a Symptom Above
Process
Three steps. Zero friction.
From arrival to assessment - seamlessly automated.
1
Patient Checks In
Patient scans a QR code or speaks to the AI intake assistant. Symptoms, history, and vitals are captured in under 2 minutes - no clipboard, no waiting.
2
AI Structures & Prioritizes
MediBridge™ converts unstructured patient language into structured clinical data, assigns acuity scores, and flags critical symptoms automatically.
3
Care Team Gets a Live Feed
Nurses and physicians see a real-time dashboard with prioritized patients, structured chief complaints, and actionable triage data - before ever entering the room.
Validation
Validated by clinical leaders.
Two Chief Medical Officers have confirmed this gap is real - and that the system is long overdue for a rebuild.
"
It really would drive efficiency and nurses would be able to do more higher-level care.
Chief Medical Officer
Major US Hospital Network
"
There are tools in this space, but nobody has stitched together the full workflow from the moment a patient enters to the moment a clinician acts.
Chief Medical Officer
US Hospital System
Roadmap
Where we are.
Completed
Clinical Validation
Two CMOs validated the problem and product approach. Confirmed the workflow gap is real and the system is overdue.
Completed
Core Platform Built
AI voice intake engine, triage scoring system, and real-time dashboard developed. Patent pending on core technology.
In Progress
Pilot Partnerships
Engaging hospital networks for initial pilot deployments. HIPAA-ready infrastructure and BAA execution in preparation.
Next
Scale & Integrate
EHR integrations, multi-department expansion, and SOC 2 Type II certification.
For Investors
Interested in what we're building?
MediBridge™ is reshaping emergency medicine infrastructure. We're connecting with healthcare-focused investors, mentors, and hospital networks who want to help us scale.
Large Market
Targeting a multi-billion dollar healthcare market with strong tailwinds and growing demand for innovation.
Defensible IP
Patent-pending technology with proprietary systems built for healthcare compliance.
Clinical Validation
Validated by senior clinical leaders. Progressing toward pilot partnerships.
Get In Touch
Let's talk.
Whether you're a clinician, hospital leader, or investor - we'd love to hear from you.
Sources & Citations
1.CDC National Center for Health Statistics. "Emergency Department Visits." National Hospital Ambulatory Medical Care Survey, 2023.
2.Hendrich, A., et al. "A 36-Hospital Time and Motion Study: How Do Medical-Surgical Nurses Spend Their Time?" The Permanente Journal, 12(3), 2008.
3.The Joint Commission. "Sentinel Event Data - Root Causes by Event Type." Sentinel Event Statistics, 2023. Miscommunication identified as a leading root cause of serious medical errors.
4.Makary, M.A. & Daniel, M. "Medical Error - The Third Leading Cause of Death in the US." BMJ, 353:i2139, 2016. Johns Hopkins study estimating over 250,000–400,000 deaths annually from preventable medical errors.
MEDIBRIDGE™ PRIVACY POLICY
Effective: April 14, 2026
1. INTRODUCTION
This Privacy Policy ("Policy") describes how Medibridge™ ("Company," "we," "our," or "us") collects, uses, discloses, and safeguards information in connection with the Medibridge™ clinical intelligence platform (the "Platform"), the website located at medibridge.info (the "Site"), and all related services. This Policy applies to healthcare provider organizations that subscribe to the Platform ("Institutional Customers"), their authorized clinical and administrative personnel ("Authorized Users"), and patients whose data is processed through the Platform ("Patients").
To the extent that the Company processes Protected Health Information ("PHI") as defined under the Health Insurance Portability and Accountability Act of 1996 ("HIPAA"), 42 U.S.C. § 1320d et seq., and its implementing regulations at 45 CFR Parts 160 and 164, such processing is governed by a Business Associate Agreement ("BAA") executed between the Company and the applicable Institutional Customer. In the event of conflict between this Policy and a BAA, the BAA controls with respect to PHI.
2. INFORMATION WE COLLECT
2.1 Information Provided Directly
We collect the following categories of information provided directly to us or submitted through the Platform:
Account and Contact Information. Names, email addresses, phone numbers, and professional titles of Authorized Users; Institutional Customer organizational information including hospital name, department, and billing details.
Clinical Data. Patient demographic information, chief complaint, symptom descriptions, medical history, medications, allergies, vital signs, triage acuity scores, provider notes, clinical orders, and shift handoff summaries. Clinical Data is processed solely on behalf of and at the direction of the applicable Institutional Customer.
Voice Data. Audio input and resulting transcriptions from the Platform's conversational voice intake module. Voice audio is processed in real time for clinical entity extraction and is not retained in audio form beyond the time required for transcription, unless the applicable BAA provides otherwise. Transcribed text is retained as part of the clinical record for the duration specified in the BAA.
2.2 Information Collected Automatically
When you access the Site or Platform, we automatically collect device information (browser type, operating system, device identifiers), server log data (IP address, access times, pages viewed, referring URLs), and usage analytics (feature usage patterns, session duration). The Platform does not use advertising cookies or third-party tracking pixels.
2.3 Information from Third-Party Sources
We receive information from Electronic Health Record systems integrated with the Platform via HL7 FHIR and HL7 v2 protocols, hospital information and registration systems, and connected vital sign monitoring devices.
3. USE OF INFORMATION
3.1 Platform Operations
We use Clinical Data and Voice Data to provide the Platform services contracted by the Institutional Customer, including processing patient intake data, generating AI-driven triage acuity scores, maintaining the live patient queue, producing automated SBAR-format shift handoff summaries, generating emergency department flow predictions, and powering the clinical dashboard.
3.2 Model Improvement
Subject to the terms of the applicable BAA and applicable law, we may use data that has been de-identified in accordance with 45 CFR § 164.514(a) (Expert Determination) or 45 CFR § 164.514(b) (Safe Harbor) to improve Platform algorithms, including triage scoring accuracy and clinical entity extraction. No attempt at re-identification of de-identified data is made or permitted. Institutional Customers may opt out of model training contributions by written notice or through their BAA.
3.3 Site and Business Operations
We use non-clinical information to operate the Site, process transactions, communicate with customers, provide support, send marketing communications where consent has been obtained, and comply with legal obligations.
4. DISCLOSURE OF INFORMATION
We do not sell personal information or PHI. We disclose information only as follows:
To Institutional Customers. Clinical Data processed through the Platform is accessible to the Institutional Customer and its Authorized Users in accordance with role-based access permissions.
Service Providers. We engage third-party processors for cloud infrastructure, speech-to-text processing, and AI model inference. All processors with access to PHI are bound by BAAs. Proprietary triage logic and API credentials are maintained exclusively in server-side functions and are not exposed to any third-party provider.
Legal Requirements. We may disclose information when required by applicable law, regulation, subpoena, court order, or governmental request, or to protect the rights, safety, or property of the Company or others.
Business Transfers. In connection with a merger, acquisition, reorganization, or asset sale, information may be transferred to the successor entity. We will provide notice before PHI becomes subject to a different privacy policy.
De-Identified and Aggregated Data. We may disclose de-identified and aggregated data that cannot reasonably identify any individual.
5. HIPAA COMPLIANCE
The Company operates as a Business Associate under HIPAA when processing PHI on behalf of Covered Entity Institutional Customers. The Company's HIPAA compliance program includes: execution of BAAs with all Institutional Customers prior to PHI access; administrative, physical, and technical safeguards required by the HIPAA Security Rule (45 CFR Part 164, Subpart C); encryption of PHI in transit (TLS 1.2 or higher) and at rest (AES-256); role-based access controls with audit logging; workforce training; breach notification procedures under the HIPAA Breach Notification Rule (45 CFR §§ 164.400-414); and periodic risk assessments.
Patients whose data is processed through the Platform should direct requests regarding access, amendment, accounting of disclosures, or restrictions to the healthcare provider that maintains their medical record. The Company will cooperate with Institutional Customers to fulfill such requests under the applicable BAA.
6. DATA SECURITY
We maintain technical, administrative, and physical safeguards to protect information from unauthorized access, use, alteration, and destruction. These safeguards include encryption of data in transit and at rest, server-side isolation of proprietary algorithms and credentials, multi-factor authentication for Authorized Users, HIPAA-compliant audit logging, periodic penetration testing, and incident response procedures. No method of electronic transmission or storage is completely secure, and we cannot guarantee absolute security.
7. COOKIES
The Site uses essential cookies required for functionality and authentication, and analytics cookies to monitor Site performance. The Platform does not deploy advertising cookies or third-party tracking technologies. Browser settings may be adjusted to refuse cookies, though doing so may impair Site functionality.
8. DATA RETENTION
Category
Retention
Basis
Clinical Data / PHI
Per BAA terms
Contractual; HIPAA
Voice Audio
Deleted after transcription
Data minimization
Voice Transcripts
Per BAA terms
Clinical record; BAA
Account Data
Duration of relationship + 3 years
Contractual; legal
Audit Logs
6 years minimum
HIPAA § 164.530(j)
Site Analytics
26 months
Business purpose
De-Identified Data
Indefinite
Not subject to HIPAA
Upon termination of an Institutional Customer relationship, PHI is returned or destroyed in accordance with the applicable BAA, subject to legally required retention.
9. INDIVIDUAL RIGHTS
9.1 Patient Rights Under HIPAA
Patients whose PHI is processed through the Platform may exercise their rights under HIPAA, including rights of access, amendment, and accounting of disclosures, by contacting the healthcare provider where they received care.
9.2 State Privacy Laws
Residents of California may have rights under the California Consumer Privacy Act (Cal. Civ. Code § 1798.100 et seq.), as amended by the California Privacy Rights Act, including rights to know, delete, correct, and opt out of the sale or sharing of personal information. PHI governed by HIPAA is exempt under CCPA § 1798.145(c)(1)(A). Residents of other states with comprehensive privacy legislation (including Virginia, Colorado, Connecticut, and others as enacted) may have comparable rights. Contact us at the address below to exercise any applicable rights.
10. CHILDREN
The Site is not directed to individuals under the age of 13. We do not knowingly collect personal information from children under 13 through the Site. The Platform may process clinical data relating to minor patients in the course of emergency department operations, under the direction of and pursuant to the BAA with the Institutional Customer.
11. CHANGES TO THIS POLICY
We may revise this Policy from time to time. We will notify Institutional Customers of material changes at least thirty (30) days before they take effect. The Effective Date above indicates the date of the most recent revision. Continued use of the Site or Platform following notice constitutes acceptance of the revised Policy.
12. CONTACT
Questions regarding this Policy may be directed to: Medibridge™ Email: jchen@medibridge.info Web: medibridge.info
These Terms of Service ("Terms") are a binding agreement between the subscribing entity ("Customer") and Medibridge™ ("Company"). By accessing or using the Medibridge™ platform (the "Platform"), the website at medibridge.info, or any related services (collectively, the "Services"), Customer agrees to these Terms. If Customer does not agree, Customer must not access the Services.
If an individual is entering into these Terms on behalf of an organization, that individual represents and warrants that they have authority to bind the organization. These Terms apply to Institutional Customers (healthcare provider organizations) and their Authorized Users (personnel granted access by Customer). Patient interactions with the Platform are governed by Customer's own consent and notice obligations under applicable law.
2. DEFINITIONS
"Authorized User" means an individual employee, contractor, or agent of Customer authorized by Customer to access the Platform.
"Business Associate Agreement" or "BAA" means the agreement between the Company and Customer governing the treatment of Protected Health Information, executed separately.
"Customer Data" means all data, including clinical, patient, and organizational data, that Customer or its Authorized Users submit to, generate within, or transmit through the Platform.
"Platform" means the Medibridge™ software, including the conversational voice intake module, triage scoring engine, patient queue, handoff summary generator, flow optimization module, and clinical dashboard.
"Protected Health Information" or "PHI" has the meaning set forth in 45 CFR § 160.103.
"Subscription Term" means the period of Customer's active subscription as specified in the applicable Order Form.
3. GRANT OF RIGHTS; SERVICES
3.1 License
Subject to these Terms and timely payment of applicable fees, the Company grants Customer a non-exclusive, non-transferable, non-sublicensable right to access and use the Platform during the Subscription Term solely for Customer's internal clinical operations.
3.2 AI and Clinical Decision Support
The Platform incorporates artificial intelligence and machine learning components. Customer acknowledges that all AI-generated triage scores, clinical recommendations, and flow predictions are decision-support outputs only and do not constitute medical advice. Authorized Users retain full clinical responsibility for patient care decisions. AI outputs may contain errors and must be validated by qualified clinical personnel before reliance. The Platform augments existing clinical workflows; it does not replace professional standards of care, clinical judgment, or applicable regulatory requirements.
3.3 Service Levels
The Company will use commercially reasonable efforts to maintain Platform availability. Specific uptime commitments, support obligations, and downtime remedies, if any, are set forth in the applicable Service Level Agreement attached as an exhibit to Customer's Order Form.
4. CUSTOMER OBLIGATIONS
4.1 Account Security
Customer is responsible for maintaining the confidentiality of all account credentials, ensuring Authorized User compliance with these Terms, notifying the Company promptly of any unauthorized access or security incident, and deactivating Authorized User access upon role change or employment termination.
4.2 Restrictions on Use
Customer shall not, and shall ensure that Authorized Users do not:
Use the Platform for any purpose other than clinical operations and emergency department workflow management;
Reverse engineer, decompile, disassemble, or attempt to derive the source code, algorithms, or data models of the Platform;
Circumvent, disable, or interfere with security features or access controls;
Use the Platform to develop, directly or indirectly, a competing product or service;
Share account credentials or permit access by unauthorized persons;
Submit data that Customer lacks the legal right to process or that violates applicable law; or
Use the Platform in violation of HIPAA, applicable state health information privacy laws, or other healthcare regulations.
4.3 HIPAA Obligations
Customer represents that it is a Covered Entity or Business Associate under HIPAA and that it has obtained all consents, authorizations, and notices required for the processing of PHI through the Platform. Customer and the Company shall execute a BAA prior to any transmission of PHI.
4.4 Clinical Responsibility
Customer acknowledges that the Company does not practice medicine and does not provide medical advice. Customer retains sole responsibility for all clinical decisions, patient care outcomes, compliance with standards of care, and adherence to licensing and credentialing requirements.
5. FEES AND PAYMENT
5.1 Subscription Fees
Customer shall pay the fees specified in the applicable Order Form. Unless otherwise stated, fees are invoiced monthly in advance and are non-refundable except as expressly provided herein or in a separate written agreement.
5.2 Fee Adjustments
The Company may adjust fees upon renewal by providing not less than sixty (60) days' written notice before the start of a renewal period.
5.3 Late Payment
Amounts past due bear interest at the lesser of 1.5% per month or the maximum rate permitted by law. The Company may suspend Platform access if fees remain unpaid more than thirty (30) days past the due date, provided the Company gives at least fifteen (15) days' prior written notice of intended suspension.
6. OWNERSHIP AND INTELLECTUAL PROPERTY
6.1 Customer Data
Customer retains all right, title, and interest in Customer Data. The Company acquires no ownership interest in Customer Data by virtue of providing the Services and processes Customer Data solely as necessary to perform and improve the Services, subject to these Terms and the applicable BAA.
6.2 De-Identified Data
Subject to the BAA, the Company may generate de-identified and aggregated datasets from Customer Data in compliance with 45 CFR § 164.514. De-identified data is not Customer Data and may be used by the Company for product development, research, benchmarking, and model training purposes.
6.3 Company Intellectual Property
The Company retains all right, title, and interest in the Platform, including all software, algorithms, models, user interfaces, documentation, and related intellectual property. Nothing in these Terms grants Customer any rights in Company intellectual property except the limited access right in Section 3.1. Proprietary triage scoring algorithms, machine learning models, and inference logic are maintained exclusively in server-side processing environments and are not accessible to Customer, Authorized Users, or third-party processors.
6.4 Feedback
If Customer provides suggestions, enhancement requests, or other feedback ("Feedback"), Customer grants the Company a non-exclusive, royalty-free, perpetual, irrevocable, worldwide license to use and incorporate Feedback into the Services without restriction or obligation.
7. CONFIDENTIALITY
"Confidential Information" means non-public business, technical, or financial information disclosed by one party to the other in connection with these Terms. Each party agrees to protect the other's Confidential Information with at least the same degree of care it uses for its own confidential information, but not less than reasonable care. PHI is governed by the BAA and not this Section. Confidential Information excludes information that: (a) is or becomes publicly available without fault of the receiving party; (b) was known to the receiving party before disclosure; (c) is received from a third party without restriction; or (d) is independently developed without reference to the disclosing party's Confidential Information.
8. REPRESENTATIONS; DISCLAIMER
8.1 Company Representations
The Company represents that: (a) the Platform will perform materially in accordance with its documentation during the Subscription Term; (b) Services will be performed in a professional manner consistent with generally accepted industry standards; and (c) the Company maintains commercially reasonable safeguards for the security, confidentiality, and integrity of Customer Data.
8.2 Disclaimer
EXCEPT AS SET FORTH IN SECTION 8.1, THE SERVICES ARE PROVIDED "AS IS" AND "AS AVAILABLE." THE COMPANY DISCLAIMS ALL OTHER WARRANTIES, WHETHER EXPRESS, IMPLIED, OR STATUTORY, INCLUDING WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, AND NON-INFRINGEMENT. THE COMPANY DOES NOT WARRANT UNINTERRUPTED OR ERROR-FREE OPERATION, THE ACCURACY OF AI-GENERATED OUTPUTS, OR THAT THE PLATFORM WILL SATISFY ALL OF CUSTOMER'S REQUIREMENTS. THE PLATFORM IS NOT A SUBSTITUTE FOR PROFESSIONAL MEDICAL JUDGMENT.
9. LIMITATION OF LIABILITY
9.1 Liability Cap
EXCEPT FOR OBLIGATIONS UNDER SECTIONS 4.2, 7, OR 10, NEITHER PARTY'S AGGREGATE LIABILITY ARISING OUT OF OR RELATING TO THESE TERMS SHALL EXCEED THE TOTAL FEES PAID OR PAYABLE BY CUSTOMER IN THE TWELVE (12) MONTHS PRECEDING THE CLAIM.
9.2 Consequential Damages Exclusion
NEITHER PARTY SHALL BE LIABLE FOR INDIRECT, INCIDENTAL, SPECIAL, CONSEQUENTIAL, OR PUNITIVE DAMAGES, OR LOSS OF PROFITS, REVENUE, DATA, OR BUSINESS OPPORTUNITY, REGARDLESS OF THEORY OF LIABILITY OR WHETHER ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
9.3 Clinical Outcomes
THE COMPANY SHALL NOT BE LIABLE FOR CLINICAL OUTCOMES, PATIENT HARM, OR TREATMENT DECISIONS MADE BY CUSTOMER OR ITS AUTHORIZED USERS. ALL AI-GENERATED OUTPUT IS ADVISORY. CLINICAL RESPONSIBILITY RESTS SOLELY WITH THE TREATING PROVIDER.
10. INDEMNIFICATION
10.1 By the Company
The Company will defend, indemnify, and hold harmless Customer from third-party claims alleging that the Platform infringes a United States patent, copyright, or trademark, and will pay resulting damages or settlement amounts, provided Customer: (a) gives prompt written notice; (b) grants sole control of defense and settlement; and (c) provides reasonable cooperation.
10.2 By Customer
Customer will defend, indemnify, and hold harmless the Company from third-party claims arising from: (a) Customer's use of the Platform in violation of these Terms; (b) Customer Data or Customer's failure to obtain required consents; (c) Customer's clinical decisions or patient care; or (d) Customer's violation of applicable law.
11. TERM AND TERMINATION
11.1 Term and Renewal
The initial Subscription Term is set forth in the Order Form. Unless either party delivers written notice of non-renewal at least sixty (60) days before expiration, the term renews automatically for successive twelve (12) month periods at the then-current fees.
11.2 Termination for Cause
Either party may terminate for material breach upon thirty (30) days' written notice if the breach remains uncured at the end of the notice period.
11.3 Termination for Convenience
Either party may terminate for any reason upon ninety (90) days' written notice.
11.4 Post-Termination
Upon termination: (a) Customer's Platform access ceases immediately; (b) each party returns or destroys the other's Confidential Information; (c) the Company will make Customer Data available for export in a structured, machine-readable format (CSV, JSON, or FHIR bundle) for ninety (90) days at no additional charge; and (d) PHI is handled in accordance with the BAA. Sections 6, 7, 8.2, 9, 10, and 14 survive termination.
12. DATA EXPORT
Upon written request during the Subscription Term or within ninety (90) days following termination, the Company will deliver Customer Data in CSV, JSON, or FHIR bundle format. Standard export requests incur no additional fees. Custom formats may be subject to professional services charges.
13. MODIFICATIONS
The Company may amend these Terms by providing at least thirty (30) days' written notice of material changes. Continued use of the Services after the revised effective date constitutes acceptance. If Customer does not accept amended Terms, Customer may terminate under Section 11.3.
14. GOVERNING LAW; DISPUTE RESOLUTION
14.1 Governing Law
These Terms are governed by the laws of the State of North Carolina, without regard to conflict-of-laws principles.
14.2 Arbitration
Disputes arising under these Terms shall first be submitted to good-faith negotiation for thirty (30) days. Unresolved disputes shall be submitted to binding arbitration administered by the American Arbitration Association under its Commercial Arbitration Rules, conducted in Forsyth County, North Carolina. Judgment on the award may be entered in any court of competent jurisdiction.
14.3 Equitable Relief
Either party may seek injunctive or equitable relief in any court of competent jurisdiction to prevent irreparable harm, without the requirement of posting a bond.
15. GENERAL
Entire Agreement. These Terms, together with any Order Form, BAA, SLA, and referenced exhibits, constitute the entire agreement between the parties and supersede all prior understandings.
Severability. If any provision is held unenforceable, the remaining provisions continue in full force.
Waiver. No waiver is effective unless written and signed by the waiving party. Failure to enforce a provision does not waive future enforcement.
Assignment. Customer may not assign these Terms without prior written consent. The Company may assign in connection with a merger, acquisition, or sale of substantially all assets, provided the assignee assumes all obligations.
Force Majeure. Neither party is liable for delays caused by events beyond reasonable control, including natural disasters, war, epidemics, government action, or infrastructure failure.
Notices. All notices must be in writing and delivered to the addresses in the applicable Order Form, or as otherwise designated in writing.
16. CONTACT
Questions regarding these Terms should be directed to: Medibridge™ Email: jchen@medibridge.info Web: medibridge.info